Clinical Trial Information
Clinical Trial Information For information on the clinical trials that our company conducts both domestically in Japan and overseas, and for which publication in international medical journals is scheduled, please use the link provided below to view our company listing on ClinicalTrials.gov, the website run by the United States National Library of Medicine.
Prev.20 | 1 | 2 | 3 | 4 | Next 20
| ClinicalTrials.gov ID | NCT01840605(2013/4 Entry) |
|---|---|
| Study Title | A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis |
| ClinicalTrials.gov ID | NCT01818687(2013/3 Entry) |
|---|---|
| Study Title | Safety and Tolerability Study of MCI-196 |
| ClinicalTrials.gov ID | NCT01814904(2013/3 Entry) |
|---|---|
| Study Title | Dose-finding Study of MCI-196 |
| ClinicalTrials.gov ID | NCT01814917(2013/3 Entry) |
|---|---|
| Study Title | Long-term Extension Study of MCI-196 |
| ClinicalTrials.gov ID | NCT01766167(2013/4 Update)※This study has been completed. |
|---|---|
| Study Title | Clinical Pharmacology Study of MP-424 in Healthy Male Adult Volunteers (Single- and Multiple-Dose Study) |
| ClinicalTrials.gov ID | NCT01764243(2013/1 Entry) |
|---|---|
| Study Title | Safety and Efficacy of MT-4666 |
| ClinicalTrials.gov ID | NCT01756703(2012/12 Entry) |
|---|---|
| Study Title | A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria |
| ClinicalTrials.gov ID | NCT01756716(2012/12 Entry) |
|---|---|
| Study Title | A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR |
| ClinicalTrials.gov ID | NCT01753557(2012/12 Entry) |
|---|---|
| Study Title | Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C |
| ClinicalTrials.gov ID | NCT01753570(2012/12 Entry) |
|---|---|
| Study Title | Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC) |
| ClinicalTrials.gov ID | NCT01742052(2012/12 Entry) |
|---|---|
| Study Title | Dose-finding Study of MT-1303 |
| ClinicalTrials.gov ID | NCT01680159(2012/9 Entry) |
|---|---|
| Study Title | A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis |
| ClinicalTrials.gov ID | NCT01666327(2012/8 Entry) |
|---|---|
| Study Title | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of MT-1303 in Subjects With Inflammatory Bowel Disease |
| ClinicalTrials.gov ID | NCT01660243(2012/8 Entry) |
|---|---|
| Study Title | Safety and Efficacy of MT-9938 |
| ClinicalTrials.gov ID | NCT01626872(2012/6 Entry) |
|---|---|
| Study Title | Long-Term Study of MP-214 in Patients With Schizophrenia |
| ClinicalTrials.gov ID | NCT01626885(2012/6 Entry) |
|---|---|
| Study Title | A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia |
| ClinicalTrials.gov ID | NCT01626859(2012/6 Entry) |
|---|---|
| Study Title | Pharmacokinetic Study of MP-214 in Patients With Schizophrenia |
| ClinicalTrials.gov ID | NCT01625897(2012/6 Entry) |
|---|---|
| Study Title | A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia |
| ClinicalTrials.gov ID | NCT01625000(2012/6 Entry) |
|---|---|
| Study Title | Safety and Efficacy of MP-214 in Patients With Schizophrenia |
| ClinicalTrials.gov ID | NCT01596335(2012/5 Entry) |
|---|---|
| Study Title | Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease |
